Cyber attacks: The new headache for drug regulators reviewing Covid-19 vaccines
Germany’s BioNTech has said the hackers who breached EU drug regulator European Medicines Agency had accessed documents relating to the regulatory submission for the Pfizer-BioNTech Covid-19 vaccine candidate.
Three pharma companies have applied for emergency use authorisation of their COVID-19 vaccines in India
EU drug regulator European Medicines Agency, which is reviewing the emergency-use applications filed by Pfizer-BioNTech and Moderna for their respective Covid-19 vaccines, has been hit by a cyberattack.
The Amsterdam-based regulatory agency said it has swiftly launched a full investigation, in close cooperation with law enforcement and other relevant entities. The EMA, however, didn’t indicate who was behind the attack or what was the motive behind the breach of its systems.
Explained: The Pfizer/BioNTech vaccine induced severe allergic reactions in the UK. How serious is it? Implications for India
The UK drug regulator MHRA has recommended people with a history of anaphylaxis or severe allergic reaction to a medicine or food to avoid Pfizer-BioNTech Covid-19 vaccine, following two reports of anaphylaxis and one report of a possible allergic reaction following immunisation.
COVID-19 vaccine (representative image)
The UK drug regulator MHRA has recommended people with a history of anaphylaxis or severe allergic reaction to a medicine or food to avoid the Pfizer-BioNTech Covid-19 vaccine, following two reports of anaphylaxis and one report of a possible allergic reaction following immunisation.